COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT02688985
Brief Title: Study to Explore the Mechanism of Action of Ocrelizumab and B-Cell Biology in Participants With Relapsing Multiple Sclerosis (RMS) or Primary Progressive Multiple Sclerosis (PPMS)

First Submitted : February 18, 2016
First Submitted that Met QC Criteria : February 18, 2016
First Posted : February 23, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : April 29, 2020
Last Update Posted : April 30, 2020